Conference Chair Invitation Letter for SMi’s Pharmaceutical Microbiology East Coast
SMi Reports: Lynne Ensor the conference chair has invited fellow microbiologists to join her at upcoming SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference.
Boston, MA, June 22, 2020 --(PR.com)-- Lynne Ensor, Vice President at Technical, Parexel International, will be chairing this year 3rd Annual Conference on Pharmaceutical Microbiology East Coast Conference and on behalf of SMi Group, has invited microbiologists to join this compelling two-day conference and post-conference workshops in Boston, USA on October 28th to 30th, 2020.
Interested parties can join the conference by registering at http://www.microbiologyeastcoast.com/pr7 and save US$300 only available until June 30th, 2020.
Dr Lynne Ensor as a 21-year veteran of the FDA her areas of expertise include biopharmaceutical sterile product manufacturing and testing, pharmaceutical microbiology, pharmacy compounding, and regulatory policy development. Her previous FDA management positions include serving as the Director of the OPF’s Division of Microbiology Assessment, Director of the OPS’s New and Generic Drug Product Quality Microbiology staff, and Director of OGD’s Division of Microbiology. Lynne was previously employed at Roche Biomedical Laboratories, the University of Maryland at Baltimore’s School of Medicine, and earned her B.S. in Biology and Ph.D. in Microbiology from the University of Maryland, College Park.
Conference chair Lynne Ensor has sent out the declared:
“I have recently transitioned from the U.S. Food and Drug Administration where I was a regulator for nearly 21 years supporting the manufacture of quality, safe and effective biopharmaceuticals. As a microbiologist and former regulatory, I am keenly aware that it is critical in our industry to maintain awareness of the regulatory expectations for intended global markets, advancing technological developments, and lessons learned from those with experience with the implementation of emerging technologies into their manufacturing and/or testing procedures.
“The conference aims to provide attendees with the most current information regarding pharmaceutical microbiology and contamination control trends in the industry, as well providing them with tools regarding regulatory expectations associated with them.
“Conference topics to be showcased include regulatory guidance's and expectations for both sterile and non-sterile biopharmaceuticals with regard to microbial control, risk identification and mitigation strategies for contamination control of manufacturing processes and facilities, microbial contamination control of the environment and operators, alternative methods for endotoxin's and microbiological testing; microbial control strategies for pharmacy compounding facilities, and provide lessons learned from current GMP inspection of facilities manufacturing sterile or non-sterile drugs.”
The brochure with full sessions and speakers is now available on the conference website and for those interested in attending, registration is available at http://www.microbiologyeastcoast.com/PR7
Sponsored By: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA, Microbiologics, Millipore Sigma
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
Pharmaceutical Microbiology East Coast 2020
Conference: October 28th-29th, 2020
Workshops: October 30th, 2020
Sheraton Boston Hotel, Boston, USA
http://www.microbiologyeastcoast.com/PR7
#SMiPharmaMicroEC
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses, and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Interested parties can join the conference by registering at http://www.microbiologyeastcoast.com/pr7 and save US$300 only available until June 30th, 2020.
Dr Lynne Ensor as a 21-year veteran of the FDA her areas of expertise include biopharmaceutical sterile product manufacturing and testing, pharmaceutical microbiology, pharmacy compounding, and regulatory policy development. Her previous FDA management positions include serving as the Director of the OPF’s Division of Microbiology Assessment, Director of the OPS’s New and Generic Drug Product Quality Microbiology staff, and Director of OGD’s Division of Microbiology. Lynne was previously employed at Roche Biomedical Laboratories, the University of Maryland at Baltimore’s School of Medicine, and earned her B.S. in Biology and Ph.D. in Microbiology from the University of Maryland, College Park.
Conference chair Lynne Ensor has sent out the declared:
“I have recently transitioned from the U.S. Food and Drug Administration where I was a regulator for nearly 21 years supporting the manufacture of quality, safe and effective biopharmaceuticals. As a microbiologist and former regulatory, I am keenly aware that it is critical in our industry to maintain awareness of the regulatory expectations for intended global markets, advancing technological developments, and lessons learned from those with experience with the implementation of emerging technologies into their manufacturing and/or testing procedures.
“The conference aims to provide attendees with the most current information regarding pharmaceutical microbiology and contamination control trends in the industry, as well providing them with tools regarding regulatory expectations associated with them.
“Conference topics to be showcased include regulatory guidance's and expectations for both sterile and non-sterile biopharmaceuticals with regard to microbial control, risk identification and mitigation strategies for contamination control of manufacturing processes and facilities, microbial contamination control of the environment and operators, alternative methods for endotoxin's and microbiological testing; microbial control strategies for pharmacy compounding facilities, and provide lessons learned from current GMP inspection of facilities manufacturing sterile or non-sterile drugs.”
The brochure with full sessions and speakers is now available on the conference website and for those interested in attending, registration is available at http://www.microbiologyeastcoast.com/PR7
Sponsored By: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA, Microbiologics, Millipore Sigma
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
Pharmaceutical Microbiology East Coast 2020
Conference: October 28th-29th, 2020
Workshops: October 30th, 2020
Sheraton Boston Hotel, Boston, USA
http://www.microbiologyeastcoast.com/PR7
#SMiPharmaMicroEC
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses, and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Simi Sapal
+44 (0) 20 7827 6020
http://www.microbiologyeastcoast.com/PR7
Simi Sapal
+44 (0) 20 7827 6020
http://www.microbiologyeastcoast.com/PR7
Contact
Categories